As we prepare to enter the third quarter, attention turns to several key FDA decisions expected in July. Beyond the pending regulatory milestones, this month also highlights broader public health priorities.
July is recognized as Sarcoma Awareness Month, aiming to raise awareness about this rare and often aggressive form of cancer. World Hepatitis Day, observed on July 28, highlights the global impact of chronic hepatitis B and C - diseases that can lead to serious liver damage and liver cancer, often without noticeable symptoms. The World Health Organization (WHO) has set a goal to eliminate hepatitis as a public health threat by 2030.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com